Kyle Anderson is the Project Leader of HDX-MS for Biopharmaceutical Analysis at the National Institute of Standards and Technology (NIST) and located at the Institute for Bioscience at Biotechnology Research (IBBR). In addition to using HDX-MS to characterize the structural dynamics of proteins, he is active in developing and promoting adoption of state-of-the-art methods, instrumentation, and software for HDX-MS to ensure quality and accelerate development of biotherapeutics and biosimilars. He received the U.S. Department of Commerce Silver Medal in 2021 and Bronze Medal in 2023.